Micot Pharma Reports Stable Share Base for July 2026, Confirms Public Float Compliance

Bulletin Express

Aug 04

Shaanxi Micot Pharmaceutical Technology Co., Ltd. (Micot Pharma) filed its monthly return for the period ended 31 July 2026, indicating no changes to either its registered or issued share capital during the month.

The company’s registered share capital stood unchanged at RMB 6.63 million, comprising 280.07 million H shares and 51.67 million domestic shares, each with a par value of RMB 0.02.

Issued shares mirrored the registered figures, with 280.07 million H shares and 51.67 million domestic shares outstanding. No treasury shares were held or created, and the aggregate issued share count remained 331.74 million.

Micot Pharma confirmed that the public float for its H-share class met the initial prescribed threshold of 24.84 percent as required by the Hong Kong Stock Exchange.

The company reported no share options, warrants, convertible securities, or other equity-linked instruments outstanding or issued during the month. The filing was signed by Executive Director Wang Bing on 4 August 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1164063868"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1164063868\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1164063868?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-04 17:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1164063868","market":"us","top_or_hot":-1,"title":"Micot Pharma Reports Stable Share Base for July 2026, Confirms Public Float Compliance","media":"Bulletin Express","content":"<p>Shaanxi Micot Pharmaceutical Technology Co., Ltd. (Micot Pharma) filed its monthly return for the period ended 31 July 2026, indicating no changes to either its registered or issued share capital during the month.</p>\n<p>The company’s registered share capital stood unchanged at RMB 6.63 million, comprising 280.07 million H shares and 51.67 million domestic shares, each with a par value of RMB 0.02.</p>\n<p>Issued shares mirrored the registered figures, with 280.07 million H shares and 51.67 million domestic shares outstanding. No treasury shares were held or created, and the aggregate issued share count remained 331.74 million.</p>\n<p>Micot Pharma confirmed that the public float for its H-share class met the initial prescribed threshold of 24.84 percent as required by the Hong Kong Stock Exchange.</p>\n<p>The company reported no share options, warrants, convertible securities, or other equity-linked instruments outstanding or issued during the month. The filing was signed by Executive Director Wang Bing on 4 August 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Micot Pharma Reports Stable Share Base for July 2026, Confirms Public Float Compliance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMicot Pharma Reports Stable Share Base for July 2026, Confirms Public Float Compliance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-04 17:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shaanxi Micot Pharmaceutical Technology Co., Ltd. (Micot Pharma) filed its monthly return for the period ended 31 July 2026, indicating no changes to either its registered or issued share capital during the month.</p>\n<p>The company’s registered share capital stood unchanged at RMB 6.63 million, comprising 280.07 million H shares and 51.67 million domestic shares, each with a par value of RMB 0.02.</p>\n<p>Issued shares mirrored the registered figures, with 280.07 million H shares and 51.67 million domestic shares outstanding. No treasury shares were held or created, and the aggregate issued share count remained 331.74 million.</p>\n<p>Micot Pharma confirmed that the public float for its H-share class met the initial prescribed threshold of 24.84 percent as required by the Hong Kong Stock Exchange.</p>\n<p>The company reported no share options, warrants, convertible securities, or other equity-linked instruments outstanding or issued during the month. The filing was signed by Executive Director Wang Bing on 4 August 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02335","symbol_name":"麦科医药-B","start_time":0,"source_url":"","article_id":"1164063868","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1164063868","pubTimestamp":1785834631,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shaanxi Micot Pharmaceutical Technology Co., Ltd. (Micot Pharma) filed its monthly return for the period ended 31 July 2026, indicating no changes to either its registered or issued share capital...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02335":"麦科医药-B"},"translate_title":"Micot Pharma 报告 2026 年 7 月股份基础稳定，确认符合公开发行要求","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02335":1},"content_text":"Shaanxi Micot Pharmaceutical Technology Co., Ltd. (Micot Pharma) filed its monthly return for the period ended 31 July 2026, indicating no changes to either its registered or issued share capital during the month.\nThe company’s registered share capital stood unchanged at RMB 6.63 million, comprising 280.07 million H shares and 51.67 million domestic shares, each with a par value of RMB 0.02.\nIssued shares mirrored the registered figures, with 280.07 million H shares and 51.67 million domestic shares outstanding. No treasury shares were held or created, and the aggregate issued share count remained 331.74 million.\nMicot Pharma confirmed that the public float for its H-share class met the initial prescribed threshold of 24.84 percent as required by the Hong Kong Stock Exchange.\nThe company reported no share options, warrants, convertible securities, or other equity-linked instruments outstanding or issued during the month. The filing was signed by Executive Director Wang Bing on 4 August 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}